MSTR EVP trades via Rule 10b5-1: exercises and sells 10,668
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Strategy Inc (MSTR) reported insider transactions by its EVP & General Counsel. On November 10–11, 2025, the officer exercised a total of 10,668 employee stock options at an exercise price of $69.123 per share and sold 10,668 shares of Class A common stock pursuant to a Rule 10b5-1 trading plan established on July 11, 2025.
The sales were executed at weighted average prices across multiple trades, with reported ranges from $234.25 to $250.04. Following these transactions, the officer beneficially owned 12,726 Class A common shares directly. The filing notes 189,332 employee stock options remaining outstanding with an expiration date of February 23, 2031. The officer previously informed the issuer of an intention to retire effective December 31, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 10,668 shares ($2,583,274)
Net Sell
12 txns
Insider
Shao Wei-Ming
Role
EVP & General Counsel
Sold
10,668 shs ($2.58M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 5,334 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,334 | $69.123 | $369K |
| Sale | Class A Common Stock | 3,206 | $234.749 | $753K |
| Sale | Class A Common Stock | 1,539 | $235.594 | $363K |
| Sale | Class A Common Stock | 589 | $236.455 | $139K |
| Exercise | Employee Stock Option (Right to buy) | 5,334 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,334 | $69.123 | $369K |
| Sale | Class A Common Stock | 3,767 | $248.942 | $938K |
| Sale | Class A Common Stock | 1,567 | $249.555 | $391K |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to buy) — 189,332 shares (Direct);
Class A Common Stock — 18,060 shares (Direct);
Series A Perpetual Strife Preferred Stock — 500 shares (Direct);
Series A Perpetual Stretch Preferred Stock — 15,000 shares (Direct);
Series A Perpetual Stride Preferred Stock — 3,527 shares (Direct)
Footnotes (1)
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025. As previously disclosed in Strategy Inc's ("Strategy") Current Report on Form 8-K filed with the Securities and Exchange Commission on July 1, 2025, the reporting person informed the issuer of his intention to retire effective December 31, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.435 to $249.40, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.52 to $250.04, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.25 to $235.17, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.39 to $236.235, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The 5,334 shares exercised on November 10, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 194,666 shares subject to this option, 44,666 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025. The 5,334 shares exercised on November 11, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 189,332 shares subject to this option, 39,332 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025.
FAQ
What did MSTR disclose in this Form 4?
The EVP & General Counsel exercised 10,668 stock options at $69.123 and sold 10,668 Class A shares under a Rule 10b5-1 plan on November 10–11, 2025.
Were the MSTR transactions executed under a Rule 10b5-1 plan?
Yes. The filing states they were effected pursuant to a Rule 10b5-1 trading plan established on July 11, 2025.
How many MSTR options remain outstanding after these transactions?
The filing shows 189,332 employee stock options remaining, with an expiration date of February 23, 2031.
Did the officer provide any future employment update at MSTR?
Yes. The officer informed the issuer of an intention to retire effective December 31, 2025.